Concepedia

Haemorrhagic Colitis Caused by Dasatinib

Nishant Patodi, Nidhi Sagar, Zbigniew Rudzki, Gerald Langman, Naveen Sharma

Case Reports in Hematology · 2012 · 28 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Gastrointestinal bleeding appears to be a common adverse event associated with dasatinib therapy. Here we present a case of a 59-year-old man with chronic myeloid leukaemia (CML) developing the rarest complication of haemorrhagic colitis with dasatinib therapy which resolved rapidly after treatment withdrawal.

References

13

Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

Per Lindahl, Bengt R. Johansson, Per Levéen et al. · Science · 1997 · 2.2K citations · Full text

, , +15

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

, , +15

Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

Louis J. Lombardo, Francis Y. Lee, Ping Chen et al. · Journal of Medicinal Chemistry · 2004 · 1.3K citations · Full text

, , +13

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

Satu Mustjoki, Marja Ekblom, T. Petteri Arstila et al. · Leukemia · 2009 · 320 citations

, , +14

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

Alfonso Quintás‐Cardama, Xin Han, Hagop M. Kantarjian et al. · Blood · 2009 · 204 citations · Full text

, , +16